These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Judd LL; Rapaport MH; Yonkers KA; Rush AJ; Frank E; Thase ME; Kupfer DJ; Plewes JM; Schettler PJ; Tollefson G Am J Psychiatry; 2004 Oct; 161(10):1864-71. PubMed ID: 15465984 [TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. Barbosa L; Berk M; Vorster M J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240 [TBL] [Abstract][Full Text] [Related]
5. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125 [TBL] [Abstract][Full Text] [Related]
6. A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Fava M; Amsterdam JD; Deltito JA; Salzman C; Schwaller M; Dunner DL Ann Clin Psychiatry; 1998 Dec; 10(4):145-50. PubMed ID: 9988054 [TBL] [Abstract][Full Text] [Related]
7. Do children and adolescents have differential response rates in placebo-controlled trials of fluoxetine? Mayes TL; Tao R; Rintelmann JW; Carmody T; Hughes CW; Kennard BD; Stewart SM; Emslie GJ CNS Spectr; 2007 Feb; 12(2):147-54. PubMed ID: 17277715 [TBL] [Abstract][Full Text] [Related]
8. Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder. Weihs KL; Murphy W; Abbas R; Chiles D; England RD; Ramaker S; Wajsbrot DB J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):36-46. PubMed ID: 29189044 [TBL] [Abstract][Full Text] [Related]
10. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group. Zisook S; Peterkin J; Goggin KJ; Sledge P; Atkinson JH; Grant I J Clin Psychiatry; 1998 May; 59(5):217-24. PubMed ID: 9632030 [TBL] [Abstract][Full Text] [Related]
11. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial. Detke HC; DelBello MP; Landry J; Usher RW J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187 [TBL] [Abstract][Full Text] [Related]
12. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522 [TBL] [Abstract][Full Text] [Related]
13. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. Rabkin JG; Wagner GJ; Rabkin R Am J Psychiatry; 1999 Jan; 156(1):101-7. PubMed ID: 9892304 [TBL] [Abstract][Full Text] [Related]
14. A fixed-dose clinical trial of fluoxetine in outpatients with major depression. Fabre LF; Putman HP J Clin Psychiatry; 1987 Oct; 48(10):406-8. PubMed ID: 3312176 [TBL] [Abstract][Full Text] [Related]
15. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Berman RM; Darnell AM; Miller HL; Anand A; Charney DS Am J Psychiatry; 1997 Jan; 154(1):37-43. PubMed ID: 8988956 [TBL] [Abstract][Full Text] [Related]
16. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Hellerstein DJ; Yanowitch P; Rosenthal J; Samstag LW; Maurer M; Kasch K; Burrows L; Poster M; Cantillon M; Winston A Am J Psychiatry; 1993 Aug; 150(8):1169-75. PubMed ID: 8328559 [TBL] [Abstract][Full Text] [Related]
17. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Lecrubier Y; Clerc G; Didi R; Kieser M Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829 [TBL] [Abstract][Full Text] [Related]
20. Novel Augmentation Strategies in Major Depression. Martiny K Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]